HIGHLIGHTS
- who: GBM subtypes and colleagues from the Laboratory for Human Molecular Genetics, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia have published the research: Current Opportunities for Targeting Dysregulated Neurodevelopmental Pathways in Glioblastoma, in the Journal: Cells 2022, 11, 2530. of /2022/
- what: In this review the authors intended to summarize and discuss current literature data and therapeutic modalities focused on targeting dysregulated pathways in A better understanding of opportunities for targeting pathways that influences malignant behavior of cells might open the way for the development of novel GBMtargeted therapies. Having . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.